CAREDX INC (CDNA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CDNA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CDNA | Independent Director | 55 | ["Senior Vice President, CFO - Neogen Corporation (Nasdaq: NEOG) (2025-present)","Independent Director, Member of the Audit Committee, Member of the Remuneration Committee - Immunovia AB (2025 - present)","Senior Vice President, CFO - North America, BioMerieux (2025)","CFO, Myriad Genetics (Nasdaq: MYGN) (2014 – 2024)","Interim President and CEO, Myriad Genetics (Nasdaq: MYGN) (2020)","Senior Vice President, Corporate Finance, Laboratory Corporation of America (LabCorp) (NYSE: LH) (2004-2014)","Financial Planning and Analysis","Strategic Planning","Risk Management","Compliance and Regulatory Standards","Treasury","Certified Public Accountant licensed in the state of North Carolina"] | ["Audit & Finance Committee (Chairman)","Compensation and Human Capital Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MYGN | Former Chief Financial Officer | [] | [] | 2025 |
Biography sourced from the proxy statement filing.
Independent Director Age: 55 Independent Director since: 2024 Committees: Audit & Finance Committee (Chairman) Professional Experience Senior Vice President, CFO - Neogen Corporation (Nasdaq: NEOG) (2025-present) Independent Director, Member of the Audit Committee, Member of the Remuneration Committee - Immunovia AB (2025 - present) Senior Vice President, CFO - North America, BioMerieux (2025) CFO, Myriad Genetics (Nasdaq: MYGN) (2014 2024) Interim President and CEO, Myriad Genetics (Nasdaq: MYGN) (2020) Senior Vice President, Corporate Finance, Laboratory Corporation of America (LabCorp) (NYSE: LH) (2004-2014) Key Skills & Qualifications Financial Planning and Analysis Strategic Planning Risk Management Compliance and Regulatory Standards Treasury Certified Public Accountant licensed in the state of North Carolina Current Organizations Neogen Corporation Previous Organizations BioMerieux Myriad Genetics Laboratory Corporation of America (LabCorp) General Electric KPMG Education M.B.A., Northwestern University B.A. (Political Science), University of North Carolina at Chapel Hill B.A. (Accounting), North Carolina State University